However, when the same clones were challenged in vivo by subcutaneous injection in syngeneic BALB/c mice, a trend for Rnaset2-mediated decrease of tumor growth rate was observed (Figure 2B) even though there was no impact on rate of survival in mice (Figure 2C). The gene discussed is RNASET2; the disease is neoplasm.